Overview

Gender

male

Investor Type

Investment Partner

Adam Stern has built his career around his passion for innovation and his entrepreneurial spirit. Formerly Senior Managing Director at Spencer Trask Ventures, Adam Stern has more than 25 years of venture capital and investment banking experience focusing primarily on the life science and technology sectors of the capital markets.

Adam Stern has completed over 100 transactions throughout his career, including private placements, public offerings, and mergers and acquisitions, with an aggregate value in excess of a billion dollars.

Adam Stern has led private and public financings for a wide variety of companies.

Adam Stern currently serves as a Director of Dance Biopharm, Inc., and Matinas BioPharma Holdings, Inc.. He is a former Director of InVivo Therapeutics Holdings Corp., Organovo Holdings, Inc., Prolor Biotech, and Labstyle Innovations Corporation. In 2013, Prolor was acquired by OPKO Health, Inc. for over $500 million.

Adam Stern was Senior Managing Director at Spencer Trask Ventures from 1997 to 2012 and was at Josephthal & Co.from 1989 to 1997, most recently as Senior Vice President and Managing Director of Private Equity Marketing. Adam Stern has been a FINRA licensed securities broker since 1987 and a General Securities Principal since 1991.